Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
05/2007
05/08/2007US7214673 For therapy of psychosis and bipolar disorder
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/03/2007WO2007050726A2 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
05/03/2007WO2007050723A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
05/03/2007WO2007050353A2 Tricyclic compounds useful as oxytocin receptor agonists
05/03/2007WO2007049820A1 Heterocyclic amide compound and use thereof
05/03/2007WO2007049736A1 Concentration crystallizer and method
05/03/2007WO2007027855A3 Raf inhibitor compounds and methods of use thereof
05/03/2007WO2007009120A3 Heterotetracyclic compounds as tpo mimetics
05/03/2007US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
05/03/2007US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
05/03/2007US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
05/03/2007US20070099894 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor
05/03/2007CA2627653A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
05/03/2007CA2627497A1 Heterocyclic amide compound and use thereof
05/03/2007CA2626180A1 Tricyclic compounds useful as oxytocin receptor agonists
05/02/2007EP1778713A2 Method for labeling and purifying nucleic acids of interest present in a biological sample to be treated in a single reaction vessel
05/02/2007EP1778695A1 MONOMERS, OLIGOMERS AND POLYMERS OF THIENO[2,3-b]THIOPHENE
05/02/2007EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents
05/02/2007EP1778243A2 Substituted azepine derivatives as serotonin receptor modulators
05/02/2007EP1592694B1 Active ingredient particles with clopidogrel or a pharmaceutically acceptable salt thereof
05/02/2007EP1546134B1 Piperazine substituted aryl benzodiazepines
05/02/2007EP1458707B1 New Indol-2-one derivatives
05/02/2007EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
05/02/2007CN1956988A Mono-, oligo- and polythieno[3,2-b]thiophenes
05/02/2007CN1956973A 2-halofuryl/thienyl-3-carboxamides
05/02/2007CN1313030C Novel nutraceutical compositions comprising biotin
05/01/2007US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases
05/01/2007US7211597 Antiinflammatory agents; rheumatic diseases; anticancer agents
05/01/2007US7211394 Providingformulation comprising a nascent protein comprising an affinity marker and a photocleavable detectable label, and ) a surface comprising an acceptor molecule; and interacting affinity marker with acceptor molecule so as to form a protein coated surface
05/01/2007US7211335 Red organic light-emitting compound and organic light-emitting device comprising the same
05/01/2007CA2185394C Biotinderivate
04/2007
04/26/2007WO2007046809A1 Thieno-pyrimidine compounds having fungicidal activity
04/26/2007WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
04/26/2007WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors
04/26/2007WO2006125815A3 Tetrahydropyridothiophenes for use in the treatment of cancer
04/26/2007WO2005090359A3 Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
04/26/2007US20070093652 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands
04/26/2007US20070093482 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
04/26/2007CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
04/25/2007EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives
04/25/2007EP1776369A1 Thienopyridone carboxamides and their medical use
04/25/2007EP1084269B1 Novel peroxidase substrates and their use in catalyzed reporter deposition
04/25/2007CN1953968A Thiazole compound and use thereof
04/25/2007CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer
04/25/2007CN1951941A Thiofurantetrahydropyridine derivative optical isomer racemization method
04/25/2007CN1951940A Plavix raceme resolution method
04/25/2007CN1951917A Pyridinone derivatives for treatment of atherosclerosis
04/24/2007US7208518 antiinflammatory agents; asthma; 2-hydroxy-3-(4-hydroxy-5-methyl-2-oxo-2H-chromene-3-yl)-9-methyl-2,3-dihydro-4H-furo[3,2-c]chromene-4-one; from 4-Hydroxycoumarin and glyoxal
04/24/2007US7208500 Treating hyperproliferative disorders; N-(4,6-Dimethyl-pyridin-2-yl)-2-{3-fluoro-4-[2-(1-methyl- 1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-phenyl}-acetamide for example; receptor kinase inhibitors
04/24/2007US7208450 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
04/19/2007WO2007043835A1 Fab i inhibitor and process for preparing same
04/19/2007WO2007043581A1 Thienopyridine-2-carboxamide derivative
04/19/2007WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors
04/19/2007WO2007042906A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands
04/19/2007WO2007041790A1 Salts of proton pump inhibitors and process for preparing same
04/19/2007WO2006125813A3 Tetrahydropyridothiophenes for use in the treatment of cancer
04/19/2007WO2006116157A3 Dipeptidyl peptidase-iv inhibitors
04/19/2007US20070088049 Polymorphic forms of methyl (+)-(s) - alpha - (2-chlorophenyl)-6, 7-dihydrothieno [3,2-c]pyridine-5(4h) acetate hydrobromide, clopidogrel hydrobromide
04/19/2007US20070088048 Clopidogrel salt and polymorphic forms thereof
04/19/2007DE102005049385A1 Imidazolderivate als Inhibitoren von TAFIa Imidazole derivatives as inhibitors of TAFIa
04/19/2007DE102005048897A1 Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen Diacylindazol derivatives as inhibitors of lipases and phospholipases
04/19/2007CA2625962A1 Fab i inhibitor and process for preparing same
04/19/2007CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors
04/19/2007CA2624307A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands
04/18/2007EP1775298A1 Thienopyrazole derivative having pde7 inhibitory activity
04/18/2007EP1773843A1 Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors
04/18/2007EP1773842A1 Pyrimidothiophene compounds
04/18/2007EP1773841A1 Mixed solvate of olanzapine, method for preparing it and method for preparing form i of olanzapine therefrom
04/18/2007EP1773840A1 Substituted pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of pda-4 and/or tnf-alpha release
04/18/2007EP1773331A1 Imidazole and thiazole derivatives as antiviral agents
04/18/2007EP1390022B1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno 2,3-d|pyrimidine for the treatment of pain
04/18/2007CN1950393A Novel inhibitors of hepatitis c virus ns3 protease
04/18/2007CN1950379A Thieno[3,2-b]pyridine-6-carbonitriles as protein kinase inhibitors
04/18/2007CN1950378A Thienopyridazines as ikk inhibitors
04/18/2007CN1950377A Thienopyridines as IKK inhibitors
04/18/2007CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives
04/18/2007CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007US7206111 Sterically hindered PI-bridge nonlinear optical chromophores, processes including same, and devices therefrom
04/17/2007US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide
04/17/2007US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
04/17/2007US7205314 Compounds for the treatment of dementia related diseases
04/12/2007WO2007022268A3 Compounds and compositions as protein kinase inhibitors
04/12/2007WO2006134163A3 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
04/12/2007WO2006125531A3 Thienopyridines
04/12/2007US20070082924 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/11/2007EP1772456A1 Novel crystalline polymorphs of clopidogrel
04/11/2007EP1772455A2 Industrial process for preparation a polmorph of clopidogrel hydrogen sulphate
04/11/2007EP1771454A1 Hepatitis c inhibitor peptide analogs
04/11/2007EP1771450A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/11/2007EP1771177A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
04/11/2007EP1501838B1 A process for the preparation of clopidogrel
04/11/2007EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
04/11/2007EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents
04/11/2007CN1946714A Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
04/11/2007CN1946395A 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
04/10/2007US7202369 Decarboxylation and etherification with cyclization
04/10/2007US7202363 Thienopyridine and furopyridine kinase inhibitors
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 214